Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease

• Kenneth I. Ataga ,

  * E-mail: kataga@med.unc.edu

  Affiliation Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Julia E. Brittain,

  Affiliation Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Payal Desai,

  Affiliation Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Ryan May,

  Affiliation Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Susan Jones,

  Affiliation Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• John Delaney,

  Current address: Carolina School of Medicine, Greenville, North Carolina, United States of America

  Affiliation Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Dell Strayhorn,

  Affiliation Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Alan Hinderliter,

  Affiliation Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Nigel S. Key

  Affiliation Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯